Active project grants relating to our work in the Medicines Discovery Institute.
|Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disorders||Wellcome Trust||£4,100,000|
|α5-GABAA Receptor Modulators for the Treatment of Cognitive Impairment Associated with Huntington’s Disease||Wellcome Trust||£3,200,000|
|LIMK1 inhibitors - A novel, disease-modifying approach for the treatment of fragile X syndrome||MRC||£2,440,000|
|MICA: Valium without sedation - Non-sedating anxiolytic GABAA receptor modulators for the treatment of anxiety disorders||MRC||£2,000,000|
|Integrating genetic, clinical and phenotypic data to advance stratification, prediction and treatment in mental health||MRC||£900,000|
|Transforming Cardiff Translation||Wellcome Trust||£600,000|
|Mechanisms of aminoglyscoside ototoxicity and drug damage repair in sensory hair cells: Towards the design of otoprotective strategies||MRC||£30,000|